Pulmonary Cell News Volume 2.27 | Jul 11 2013

    0
    23
    Pulmonary Cell News 2.27 July 11, 2013

    Pulmonary Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook  Pulmonary Cell News on Twitter

     
    TOP STORY
    A Rare Population of CD24+ITGB4+Notchhi Cells Drives Tumor Propagation in NSCLC and Requires Notch3 for Self-Renewal
    To identify tumor-propagating cells relevant to lung cancer pathogenesis, researchers investigated functional heterogeneity in tumor cells isolated from Kras-driven mouse models of non-small-cell lung cancer (NSCLC). CD24+ITGB4+Notchhi cells are capable of propagating tumor growth in both a clonogenic and an orthotopic serial transplantation assay. [Cancer Cell] Abstract
    PneumaCult™-ALI Medium for Bronchial Epithelial Cells: Watch the Video

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Apoptosis Induced by the Fungal Pathogen Gliotoxin Requires a Triple Phosphorylation of Bim by JNK
    Scientists showed that gliotoxin (GT) and the supernatant of Aspergillus fumigatus (but not its GT-defective mutant) activate the JNK pathway and require a co-operative JNK-mediated BimEL phosphorylation at three sites to induce apoptosis in mouse fibroblasts, human bronchial and mouse alveolar epithelial cells. [Cell Death Differ] Abstract

    Increased Acid Stability of the Hemagglutinin Protein Enhances H5N1 Influenza Virus Growth in the Upper Respiratory Tract but Is Insufficient for Transmission in Ferrets
    Scientists investigated how a decrease in hemagglutinin (HA) activation pH influences the properties of highly pathogenic H5N1 influenza virus in mammalian hosts. The VN1203-HA2-K58I virus had similar replication kinetics compared to VN1203-wild-type in MDCK and normal human bronchial epithelial cells yet reduced growth in human alveolar A549 cells, which were found to have a higher endosomal pH than MDCK cells. [J Virol] Abstract

    Bilateral Entry and Release of Middle East Respiratory Syndrome-Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells
    The newly emerged MERS-CoV infects human bronchial epithelial Calu-3 cells. Unlike SARS-CoV which exclusively infects and releases through the apical route, this virus can do so through either side of polarized Calu-3 cells. Infection results in profound apoptosis within 24 hours irrespective of its production of titers that are lower than those of SARS-CoV. [J Virol] Abstract

    Gamma-Glutamyltransferase Catabolism of S-Nitroso-Glutathione Modulates IL-8 Expression in Cystic Fibrosis Bronchial Epithelial Cells
    Scientists evaluated the effect of S-Nitrosoglutathione (GSNO) catabolism mediated by gamma-glutamyltransferase (GGT) on production of IL-8 in CFTR-mutated IB3-1 bronchial cells. The rapid, GGT-catalyzed catabolism of GSNO caused a decrease of both basal and LPS-stimulated IL-8 production in IB3-1 cells, by modulating both NF-?B and ERK1/2 pathways, along with a decrease of cell proliferation. [Free Radical Bio Med] Abstract

    Identification of Different Subsets of Lung Cells Using Raman Microspectroscopy and Whole Cell Nucleus Isolation
    Raman spectroscopy has been widely used to study its possible clinical application in cancer diagnosis. However, in order to make it into clinical practice, it is important that this technique is able not only to identify cancer cells from their normal counterparts, but also from the array of cells present in human tissues. To this purpose, the authors used Raman spectroscopy to assess whether this technique was able to differentiate not only between lung cancer cells and lung epithelial cells but also from lung fibroblasts. [Analyst] Abstract

    Diethyl Sulfate-Induced Cell Cycle Arrest and Apoptosis in Human Bronchial Epithelial 16HBE Cells
    Researchers investigated the effects of diethyl sulfate (DES) on cell proliferation, cell cycle progression and apoptosis in human bronchial epithelial 16HBE cells. The results showed that DES inhibited cell proliferation in a dose- and time-dependent manner, and induced significant apoptosis in 16HBE cells. [Chem Biol Interact] Abstract

    LUNG CANCER

    Targeted Genetic Dependency Screen Facilitates Identification of Actionable Mutations in FGFR4, MAP3K9, and PAK5 in Lung Cancer
    Investigators identified three kinases with gain-of-function mutations in lung cancer, namely FGFR4, MAP3K9, and PAK5. Mutations in these kinases are activating toward the ERK pathway, and targeted depletion of the mutated kinases inhibits proliferation, suppresses constitutive activation of downstream signaling pathways, and results in specific killing of the lung cancer cells. [Proc Natl Acad Sci USA]
    Abstract | Full Article | Press Release

    Novel Small Molecule Inhibitors of Bcl-XL to Treat Lung Cancer
    The authors identified two new Bcl-XL inhibitors that exhibit selective toxicity against lung cancer cells compared with normal human bronchial epithelial cells. Fluorescence polarization assay revealed that BXI-61 and BXI-72 preferentially bind to Bcl-XL protein but not Bcl2, Bcl-w, Bfl-1/A1 or Mcl-1 in vitro with high binding affinities. [Cancer Res] Abstract

    Nuclear Factor-?B-Mediated Inflammation Leading to EMT via miR-200c Is Involved in Cell Transformation Induced by Cigarette Smoke Extract
    Scientists evaluated the roles of inflammation and the epithelial-mesenchymal transition (EMT) in cigarette smoke extract (CSE)-induced transformation of human bronchial epithelial cells. The results showed that chronic exposure to CSE induced EMT and transformation of these cells. [Toxicol Sci] Abstract

    Involvement of TRPC Channels in Lung Cancer Cell Differentiation and the Correlation Analysis in Human Non-Small Cell Lung Cancer
    The authors investigated the involvement of canonical transient receptor potentials (TRPCs) in the cell differentiation of lung cancer. Blockade of TRPC channels inhibited A549 cell proliferation, while overexpression of TRPCs increased the proliferation. [PLoS One] Full Article

    Model the Human Respiratory Epithelium with PneumaCult™-ALI. Click to View Data.

     
    REVIEWS
    Premature Lung Aging and Cellular Senescence in the Pathogenesis of Idiopathic Pulmonary Fibrosis and COPD/Emphysema
    According to recently proposed pathogenic models in chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), premature cellular senescence likely affects distinct progenitors cells, leading to stem cell exhaustion. Mesenchymal stem cells in COPD, alveolar epithelial precursors in IPF. In this review, the large amount of data supporting this pathogenic view are discussed, with emphasis on the possible molecular and cellular mechanisms leading to the severe parenchymal remodeling that characterizes, in different ways, these deadly diseases. [Transl Res] Abstract

    Visit our reviews page to see a complete list of reviews in the pulmonary cell research field.

     
    INDUSTRY NEWS
    Cell Signaling Technology Awarded Patents Critical to Lung Cancer Therapy
    Cell Signaling Technology, Inc. announced the issuance of a key US patent, 8,481,279, which relates to methods for inhibiting the progression of lung cancers that express the EML4-ALK fusion gene. [Cell Signaling Technology, Inc.] Press Release

    Vertex Receives Australian Approval for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People with a Specific Genetic Mutation (G551D)
    Vertex Pharmaceuticals Incorporated announced that the Therapeutic Goods Administration of Australia has approved KALYDECO™ (ivacaftor) for people with cystic fibrosis ages 6 and older who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator gene. [Vertex Pharmaceuticals Incorporated] Press Release

    From our sponsor:
    View immunology lectures, protocols and other resources on the Human Immunology Portal.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Munich Lung Conference 2013
    October 4-5, 2013
    Munich, Germany

    Visit our events page to see a complete list of events in the pulmonary cell community.

     
    JOB OPPORTUNITIES
    NEW Principal Investigator – Oncology/Respiratory Medicine (The Second Affiliated Hospital of Zhejiang University School of Medicine)

    NEW Postdoctoral Fellow – ERK3 Kinase Signaling in Cancer Progression and Metastasis (Wright State University)

    NEW Postdoctoral Researcher – Molecular Determinants of Resistance to Chemotherapy and Radiation (The Ohio State University – Comprehensive Cancer Center)

    Postdoctoral Position – Idiopathic Pulmonary Fibrosis (University of Minnesota – Twin Cities)

    Postdoctoral Fellow – Translational Oncology (The University of Texas MD Anderson Cancer Center)

    Director of Cell Processing Facility (S L Collins Associates, Inc.)

    PhD Opportunity – Biofunctionalization of Liposomes for Tumor-Targeted Drug Delivery (University of East Anglia)


    Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Pulmonary Cell News? Click here to submit!

    Comments or Suggestions? Email info@connexoncreative.com with your feedback.

    Learn more about Pulmonary Cell News: Archives | Events | Contact Us